InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Shirvan Mitchell. Director active across 1 company, notably Silexion Therapeutics Corp. Cumulatively, 2 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €27k. Activity tracked since 20 February 2026. The latest transaction was filed on 26 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations